Results 81 to 90 of about 16,400 (171)

End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation. [PDF]

Front Cell Infect Microbiol, 2023
Guo Y, Han J, Zhang Y, Jin C, Zhang Y, He J, Chen S, Guo Y, Lin Y, Li F, Yang F, Shen Z, Mao R, Zhu H, Zhang J.   +14 more
europepmc   +1 more source

Differential response of HBV envelope-specific CD4 + T cells is related to HBsAg loss after stopping nucleos(t)ide analogue therapy. [PDF]

Hepatology, 2023
Li Y, Wen C, Gu S, Wang W, Guo L, Li CK, Yi X, Zhou Y, Dong Z, Fu X, Zhong S, Wang Y, Huang K, Yin J, Zhong C, Liang X, Fan R, Chen H, Jiang D, Zhang X, Sun J, Tang L, Peng J, Hou J.   +23 more
europepmc   +1 more source

Use of HBSAG Quantification To Guide HBIG Prophylaxis After Liver Transplantation

, 2014
Hepatitis B surface antigen (HBsAg) quantification has recently been introduced to guide treatment in chronic hepatitis B virus (HBV) patients.
Silvestri A, Ghinolfi D, Precisi A, Alessandro Silvestri, Leonardi G, Filipponi F., Davide Ghinolfi, Paola Carrai, Arianna Precisi, Carrai P, Paolo De Simone, Giulia Leonardi, Campani D, Franco Filipponi, De Simone P, Daniela Campani   +15 more
core   +1 more source

An Ideal Hallmark Closest to Complete Cure of Chronic Hepatitis B Patients: High-sensitivity Quantitative HBsAg Loss. [PDF]

J Clin Transl Hepatol, 2023
Wang ZL, Zheng JR, Yang RF, Huang LX, Chen HS, Feng B.   +5 more
europepmc   +1 more source

Soluble CD163 and CD163 Expression on Monocytes Associated with Chronic Hepatitis B Inflammation and HBsAg Loss. [PDF]

J Clin Transl Hepatol, 2022
Xie P, Yao B, Huang D, Chen Y, Gong Q, Zhang X.   +5 more
europepmc   +1 more source

Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients. [PDF]

Front Immunol, 2023
Wang WX, Jia R, Jin XY, Li X, Zhou SN, Zhang XN, Zhou CB, Wang FS, Fu J.   +8 more
europepmc   +1 more source

Expression of Functional Molecule on Plasmacytoid Dendritic Cells Is Associated With HBsAg Loss in HBeAg-Positive Patients During PEG-IFN α-2a Treatment. [PDF]

Front Immunol, 2022
Cao W, Xie S, Zhang L, Bi X, Lin Y, Yang L, Lu Y, Liu R, Chang M, Wu S, Shen G, Dong J, Xie Y, Li M.   +13 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients. [PDF]

Front Immunol, 2022
Li M, Zhang L, Xie S, Sun F, Zeng Z, Deng W, Jiang T, Bi X, Lin Y, Yang L, Lu Y, Shen G, Liu R, Wu S, Chang M, Hu L, Dong J, Yi W, Xie Y.   +18 more
europepmc   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source